Cite
HARVARD Citation
Gmyr, V. et al. (2017). Human Recombinant Antithrombin (ATryn®) Administration Improves Survival and Prevents Intravascular Coagulation after Intraportal Islet Transplantation in a Piglet Model. Cell transplantation. 26 (2), pp. 309-317. [Online].